U.S. market Closed. Opens in 1 day 6 hours 7 minutes

UPC | Universe Pharmaceuticals INC Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-30
Revenue32.31M40.14M47.98M30.70M33.23M
Cost of Revenue21.99M18.25M22.66M16.61M19.82M
Gross Profit10.32M21.89M25.33M14.09M13.41M
Operating Expenses13.84M28.91M11.74M3.74M3.36M
Selling, General & Admin9.00M20.84M6.27M2.80M2.29M
Research & Development4.86M7.64M5.47M583.12K618.44K
Other Operating Expenses-17.53K430.31K-80.43K365.77K445.77K
Operating Income-3.53M-7.02M13.59M10.25M9.75M
Other Expenses / Income-322.80K-545.35K88.34K-151.29K-99.77K
Before Tax Income-3.85M-7.98M13.68M10.10M9.65M
Income Tax Expenses2.31M752.42K2.36M2.54M2.10M
Net Income-6.16M-8.74M11.32M7.56M7.55M
Interest Expenses156.79K162.40K101.60K123.76K129.27K
Basic Shares Outstanding3.62M3.62M3.62M3.67M3.67M
Diluted Shares Outstanding3.62M3.62M3.62M3.67M3.67M
EBITDA-3.22M-7.33M14.20M10.61M10.17M
EBITDA Margin-9.95%-18.25%29.59%34.56%30.62%
EBIT-3.69M-7.82M13.78M10.22M9.78M
EBIT Margin-11.43%-19.48%28.72%33.30%29.44%
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙